Amrutanjan Health Care Ltd.
Snapshot View

665.25 +3.10 ▲0.5%

29 July 2021, 04:02:37 P.M.
Volume: 26,750

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.amrutanjan.com
Financial Indicators
Market Cap 1,946.18 Cr.
Earnings per share (EPS) 20.93 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 31.81 Trailing Twelve Months Ending 2021-03
Industry PE 34.39 Trailing Twelve Months Ending 2021-03
Book Value / Share 73.75 Trailing Twelve Months Ending 2021-03
Price to Book Value 9.03 Calculated using Price: 665.80
Dividend Yield 0.24 Period Ending 2020-03
No. of Shares Subscribed 2.92 Cr. 29,230,630 Shares
FaceValue 1
Company Profile

Amrutanjan Health Care was started in the year 1893 by social reformer, journalist and freedom fighter, Nageswara Rao Pantulu Garu. Today Amrutanjan is one of the household names in South India.

While Amrutanjan Pain Balm (Yellow Balm) is the flagship brand of the company with a rich heritage of over 100 years, the company is also planning to introduce a series of next generation products in healthcare category.

With a wide range of ayurvedic and allopathic products, Amrutanjan has helped millions of people relieve themselves from the pain and discomfort of headaches, colds, sprains, muscular pains, rheumatic pains and stands a real pain management specialist for its loyal customers.

The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai.  Apart from the products in the pain care segment, other categories include cough and cold care, health and home care.

Its products are available in the Gulf, African, South East and Asian countries. Plans are ready to enter the US and European markets in a big way.

Products

  • Amrutanjan pain balm
  • Dragon Roll-on liquid balm
  • Joint ache cream
  • Pain relief kit
  • Cold rub
  • Vaporising gel
  • Cough drops
  • Swas mint
  • Diakyur capsules
  • Jiffy tablets
  • Decorn (corn caps)
  • Cutis olive oil, etc.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.47%
1 Week
-3.26%
1 Month
-2.94%
3 Month
+5.51%
6 Month
+34.68%
1 Year
+71.63%
2 Year
+124.63%
5 Year
+187.24%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 14.40 14.36 15.72 16.97 19.90 18.46 16.35 17.87 16.44
Return on Capital Employed (%) 18.65 19.90 22.63 26.06 30.86 28.65 26.90 25.43 22.80
Return on Assets (%) 9.55 9.67 11.58 13.45 16.07 14.66 12.84 14.18 13.05

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 81 88 97 105 120 116 129 146 159
Non Curr. Liab. 9 3 3 2 3 1 1 2 2
Curr. Liab. 34 35 24 23 25 32 32 36 39
Minority Int.
Equity & Liab. 124 127 124 130 149 149 162 183 201
Non Curr. Assets 74 69 51 52 54 41 41 44 75
Curr. Assets 50 58 73 79 95 108 121 140 126
Misc. Exp. not W/O
Total Assets 124 127 124 130 149 149 162 183 201

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 135 135 139 163 184 212 222 253 261
Other Income 4 4 4 5 6 7 8 7 8
Total Income 139 139 143 168 190 219 230 261 270
Total Expenditure -114 -116 -116 -139 -153 -182 -194 -222 -231
PBIDT 25 24 26 29 37 37 36 38 39
Interest -3 -2 -2 -1 0 -1 0 0 0
Depreciation -3 -3 -3 -2 -3 -3 -3 -3 -4
Taxation -5 -6 -7 -9 -12 -12 -13 -10 -9
Exceptional Items 0
PAT 13 12 15 17 22 22 20 25 25

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 13 8 18 19 21 8 19 21 18
Cash Fr. Inv. 4 11 16 -5 1 0 -8 -11 -14
Cash Fr. Finan. -27 -17 -14 -12 -11 -5 -9 -7 -12
Net Change -9 2 20 2 12 3 2 3 -7
Cash & Cash Eqvt 15 9 29 31 42 25 11 15 7

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 50.02 50.02 50.02 50.02 50.02 50.02 50.02 50.02 50.02
Public 49.98 49.98 49.98 49.98 49.98 49.98 49.98 49.98 49.98
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 08 Jul 2021
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for 30/06/2021
Wed, 07 Jul 2021
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for 30/06/2021
Wed, 30 Jun 2021
Appointment
Amrutanjan Health Care Limited has informed the Exchange regarding Appointment of Mr Muralidharan Swayumbunathan as Non -Executive Independent Director of the company w.e.f. Jun 29, 2021.

Technical Scans View Details

Thu, 29 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Outperforming Sectoral Index in both 1 Week and 3 Month Stock Outperforming Sectoral Index in both 1 Week and 3 Month
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
Close Crossing Lower Bollinger Band From Below Close Crossing Lower Bollinger Band From Below
Stochastic In Oversold Zone Stochastic In Oversold Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,733.23 703.00 +2.2%
Divi's Laboratories Ltd. 128,656.69 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. 77,707.65 4,672.65 -1.2%
Cipla Ltd. 71,170.06 883.10 -0.8%
Cadila Healthcare Ltd. 58,547.84 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. 58,067.43 4,028.55 0.0%
Aurobindo Pharma Ltd. 53,214.94 908.25 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.11 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 64.84 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 44.73 4,672.65 -1.2%
Cipla Ltd. Consolidated 2021-03 29.59 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 27.44 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 386.19 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2021-03 9.98 908.25 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 13.84 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.35 4,672.65 -1.2%
Cipla Ltd. Consolidated 2021-03 3.88 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 4.51 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.64 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.43 908.25 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 0.18 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 908.25 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 10.09 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 908.25 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 12.53 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 908.25 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 17,131.99 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 908.25 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 1,546.98 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 908.25 -0.8%